T1	Participants 351 431	We used data from EORTC 22881-10882 trial, with median follow-up of 77.4 months.
T2	Participants 432 531	Patients receiving BCT and 50Gy whole breast irradiation were randomized to no boost and 16Gy boost
T3	Participants 817 833	younger patients
T4	Participants 980 1022	8.4% of the study population would receive
T5	Participants 1141 1168	67% of the study population
T6	Participants 1261 1277	younger patients
